Mark Cuban Cost Plus Drug Co. is disrupting the traditional hospital pharmaceutical purchasing model, according to leaders at ...

Companies can slash their health care spending without sacrificing quality, according to a couple of billionaires.

The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.

Employees at banking giant JPMorgan Chase claimed in a new class action suit that the company mismanaged their benefits, ...

The Cost Plus CEO discussed how corporate leaders can take a hold of their healthcare spending at a Texas Business Hall of ...

Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as ...

Optum Rx said it will similarly transition client arrangements such as employer and health plan customers - to ensure transparency and greater alignment to drug costs. It has already started ...